1-9 of 9
Marcos deLima, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/ Refractory Acute Myeloid Leukemia (AML)

Anjali S. Advani, MD, Brenda Cooper, MD, Paul Elson, PhD, Sudipto Mukherjee, MD, PhD, M.P.H., Jaime Fensterl, Aaron T. Gerds, MD MS, Paolo F. Caimi, MD, Ben K. Tomlinson, MD, Ehsan Malek, MD, Jane A. Little, MD, Mary Lynn Rush, Samjhana Bogati, BSN, Eric Parsons, Donna Kane, Hetty E. Carraway, MD MBA, Aziz Nazha, MD, Betty K. Hamilton, MD, Ronald Sobecks, MD, Barbara Bevier, Christopher Goebel, Cassie Zimmerman, MPH, Alek d Nielsen, B.S., Cassandra M. Hirsch, BSc, Jaroslaw P. Maciejewski, MD, PhD, FACP, Matt Kalaycio, MD, Marcos deLima, MD, James Jacobberger, Philip Woost, Mikkael A. Sekeres, MD MS
Journal: Blood
Blood (2016) 128 (22): 4065.
https://doi.org/10.1182/blood.V128.22.4065.4065
Published: 2016
Journal Articles

Low Dose Antithymocyte Globulin (ATG) for Graft-Versus-Host Disease (GVHD) Prophylaxis

Anand Tandra, MD, Leland Metheny, MD, David Yao, MD PhD, Paolo F. Caimi, MD, Lauren Brister, CNP, Brenda Cooper, MD, Hillard M. Lazarus, MD, Ben K. Tomlinson, MD, Ehsan Malek, MD, Fahrettin Covut, MD, Raisa Pinto, MD, Marcos deLima, MD
Journal: Blood
Blood (2016) 128 (22): 5788.
https://doi.org/10.1182/blood.V128.22.5788.5788
Published: 2016
Journal Articles

Comorbidity and Outcomes for Patients Over Age 65 Years Treated with Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome

Henry J. Conter, MD, MSc, Nhu-Nhu Nguyen, Gabriela Rondon, MD, Julianne Chen, Elizabeth J Shpall, MD, Issa Khouri, MD, Sergio A Giralt, MD, Richard E. Champlin, Marcos DeLima, MD
Journal: Blood
Blood (2012) 120 (21): 2032.
https://doi.org/10.1182/blood.V120.21.2032.2032
Published: 2012
Journal Articles

A Matched Controlled Analysis of Post-Transplant Cyclophosphamide (CY) Versus Tacrolimus and Mini-Dose Methotrexate in Matched Sibling and Unrelated Donor Transplant Recipients Receiving Reduced-Intensity Conditioning: Post-Transplant CY Is Associated with Higher Rates of Acute Gvhd

Amin M. Alousi, M.D., Rima M Saliba, PhD, Julianne Chen, Borje S Andersson, MD, PhD, Issa Khouri, MD, Muzaffar H. Qazilbash, MD, Uday R. Popat, M.D., Chitra M. Hosing, M.D., Stefan O. Ciurea, Elizabeth J Shpall, MD, Roy B. Jones, MD, Ph.D., Partow Kebriaei, M.D., Yago Nieto, M.D., Ph.D., Paolo Anderlini, MD, Marcos DeLima, MD, Gabriela Rondon, Richard E. Champlin
Journal: Blood
Blood (2012) 120 (21): 4200.
https://doi.org/10.1182/blood.V120.21.4200.4200
Published: 2012
Journal Articles

Final Report of a Phase II Trial of Vorinostat with Idarubicin and Cytarabine for Patients with Newly Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Guillermo Garcia-Manero, Francesco Paolo Tambaro, MD, PhD, Nebiyou Bekele, Hui Yang, Farhad Ravandi, MD, Elias Jabbour, Gautam Borthakur, Tapan Kadia, Marina Konopleva, M.D., Ph.D., Stefan Faderl, MD, Jorge E. Cortes, Mark Brandt, BS, Yumin Hu, PhD, Deborah McCue, Willie Mae Newsome, RN, Sherry Pierce, RN, BS, Marcos DeLima, MD, Hagop M. Kantarjian
Journal: Blood
Blood (2011) 118 (21): 763.
https://doi.org/10.1182/blood.V118.21.763.763
Published: 2011
Journal Articles

Determinants of Higher Pre-Apheresis CD34+ Count in Patients Undergoing Autologous Hematopoietic Stem Cell Mobilization

Alexandre Chiattone, MD, Rima M Saliba, PhD, Viviane C. Chiattone, RN, XiaoWen Tang, MD, Nelson Hamerschlak, MD, Farzaneh Maadani, Muzaffar H. Qazilbash, MD, Uday Popat, M.D., Partow Kebriaei, MD, Richard Champlin, MD, Chitra M Hosing, MD, Marcos DeLima, MD
Journal: Blood
Blood (2011) 118 (21): 4387.
https://doi.org/10.1182/blood.V118.21.4387.4387
Published: 2011
Journal Articles

Older Adults with Chronic Myelogenous Leukemia (CML), During the Tyrosine Kinase Inhibitor (TKI) Era, Can Be Successfully Treated with Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplant (HCT) Using Sibling or Unrelated Donors: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Erica D Warlick, MD, Brian McClune, DO, Tanya L. Pedersen, MPH, Kwang W Awn, PhD, Joseph H. Antin, MD, Jean-Yves Cahn, MD, Marcos DeLima, MD, Vikas Gupta, MD, FRCP, FRCPath, David I Marks, MD, Donald Bunjes, MD, John F. DiPersio, MD, PhD, Steven Devine, Daniel J. Weisdorf, MD
Journal: Blood
Blood (2011) 118 (21): 494.
https://doi.org/10.1182/blood.V118.21.494.494
Published: 2011
Journal Articles

Chemotherapy with Granulocyte Colony Stimulating Factor (G-CSF) Alone Versus Granulocyte Colony Stimulating Factor (G-CSF) Plus Granulocyte-Macrophage Stimulating Factor (GM-CSF) for Hematopoietic Progenitor Cell Mobilization in Patients with Relapsed Non-Hodgkin’s Lymphomas (NHLs).

Chitra Hosing, MD, Mark Munsell, PhD, Uday Popat, MD, Martin Körbling, MD, Rosamar Valverde, Farzaneh Maadani, Partow Kebriaei, MD, Amin Alousi, MD, Marcos DeLima, MD, John McMannis, PhD, Elizabeth J. Shpall, MD, Muzaffar H. Qazilbash, MD, Paolo Anderlini, MD, Sergio Giralt, MD, Richard Champlin, MD, Issa Khouri, MD
Journal: Blood
Blood (2007) 110 (11): 1900.
https://doi.org/10.1182/blood.V110.11.1900.1900
Published: 2007
Journal Articles

Cardiac Toxicity and Non-Relapse Mortality in Patients with Low Left Ventricular Ejection Fraction Undergoing Stem Cell Transplantation.

Diem T. Chu, MS, PA-C, Rima Saliba, PhD, Suhail Qureshi, MD, Amin Alousi, MD, Paolo Anderlini, MD, Farhan Bukhari, MD, Marcos Delima, MD, Sergio A. Giralt, MD, Partow Kebriaei, MD, Issa F. Khouri, MD, Gaurav Parik, MD, Uday Popat, MD, Elizabeth J. Shpall, MD, Wamique S. Yusuf, MD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD, Chitra Hosing, MD
Journal: Blood
Blood (2007) 110 (11): 3002.
https://doi.org/10.1182/blood.V110.11.3002.3002
Published: 2007